Jae Wha Kim

USPTO Granted Patents = 23 (Patent Applications = 11)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 32(Granted Patents)

Location History:

Seoul, KR (1991 - 2022)
Daejeon, KR (2012 - 2022)

Company Filing History:

12 out of 22

Enzychem Lifesciences Corporation

patents

12 out of 321

Korea Research Institute of Bioscience and Biotechnology

patents

2 out of 2,340

Hyundai Electronics Industries Co. Ltd.

patents

4. 1 out of 2,626

Hyundai Mobis Co., Ltd.

where one patent can have more than one assignee

Years Active: 1991-2025

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297163 - Glycerol derivative, preparation method therefor, and immunomodulator comprising same as effective ingredient (2025-05-13),

2. 12187672 - 1,2-diacylglycerol compound, preparation method therefor, and immunomodulator containing same as active ingredient (2025-01-07),

3. 11491132 - Methods for treating thrombocytopenia (2022-11-08),

4. 11454309 - Composition for worm wheel having excellent durability with wear resistance and worm wheel prepared using the same (2022-09-27),

5. 11357749 - Methods for treating neutropenia (2022-06-14),

6. 10857119 - Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis (2020-12-08),

7. 10653657 - Method for treating hemolytic uremic syndrome (2020-05-19),

8. 10596141 - Methods for treating thrombocytopenia (2020-03-24),

9. 10588886 - Methods for treating neutropenia (2020-03-17),

10. 10555923 - Method for treating paroxysmal nocturnal hemoglobinuria (2020-02-11),

11. 10058527 - Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis (2018-08-28),

12. 9895337 - Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis (2018-02-20),

13. 9763908 - Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating atopic dermatitis (2017-09-19),

14. 9481630 - Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same (2016-11-01),

15. 9428520 - Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis (2016-08-30),

Title: **Jae Wha Kim: Innovator in Immunomodulation and Inflammation Treatment**

Introduction

Jae Wha Kim is a prominent inventor based in Seoul, South Korea, recognized for his significant contributions to the field of biomedicine. With a remarkable total of 22 patents, he has dedicated his research to developing innovative solutions for various health conditions, particularly those related to inflammation.

Latest Patents

Among his latest innovations, Jae Wha Kim has developed a novel 1,2-diacylglycerol compound, which is instrumental in improving, preventing, or treating inflammation-related diseases. This compound works by inhibiting the overexpression of inflammatory cytokines, including IL-4, IL-6, and CXCL8, which are associated with the migration of inflammatory cells. The preparation method for this compound and its application as an immunomodulator are detailed in his recent patent. Additionally, Kim has provided methods for addressing thrombocytopenia and leukopenia, particularly in patients undergoing cancer chemotherapy, by administering a monoacetyl-diacyl-glycerol compound, showcasing the versatility and potential of his inventions.

Career Highlights

Jae Wha Kim has established himself as a key figure in the research community through his work at esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and Enzychem Lifesciences Corporation. His research not only reflects his scientific expertise but also his commitment to advancing healthcare solutions.

Collaborations

Throughout his career, Jae Wha Kim has collaborated with fellow researchers, including Kyung Seop Ahn and Ho Bum Kang. These partnerships have fostered a collaborative environment that enhances the development of innovative therapeutic solutions.

Conclusion

Jae Wha Kim continues to make significant strides in the field of immunology and biomedicine. His impactful patents and dedication to research reflect his role as an influential inventor, dedicated to improving health outcomes through innovative science. As he progresses in his career, the scientific community eagerly anticipates his future contributions to the field.

This text is generated by artificial intelligence and may not be accurate.